//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
From #ADA2026 - Cagrilintide–semaglutide therapy improves HbA1C levels in #Type2Diabetes that has been inadequately controlled with basal insulin given alone or alongside metformin. 👉️ buff.ly/5n5mFiS #T2D
1d
Cagrilintide–semaglutide (CagriSema) therapy improves HbA1C levels in type 2 diabetes that has been inadequately controlled with basal insulin given alone or alongside metformin.
buff.ly
REIMAGINE-3 supports cagrilintide–semaglutide for basal insulin-treated type 2 diabetes
Springer Medicine